Antidiabetes Prescriptions 15-Fold Higher Than Antiobesity Rx
Mean increase of 25,259 prescriptions per month for SGLT2s versus 5,154 for new antiobesity meds
Metformin Tied to Cardiovascular Benefits in T1DM Patients
Cells associated with blood vessel damage reduced in patients taking metformin
Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA
Findings in African-American patients with new-onset diabetic ketoacidosis and severe hyperglycemia
Rapid Improvement in Insulin Sensitivity With Bariatric Surgery
Improvements in hepatic insulin sensitivity, endogenous glucose production, lipolysis
Avoiding Dry-Cooked Foods May Help Protect Against T2DM
Researchers suggest steaming, poaching, and stewing for better health
Long-Term Follow-Up Shows Bariatric Patients Keep Weight Off
10-year follow-up study finds many who had gastric bypass surgery maintained weight loss
August 2016 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2016. This roundup includes...
Dapagliflozin Improves Insulin Sensitivity in Type 2 Diabetes
Decrease in basal glucose oxidation; increases in lipid oxidation, plasma ketone concentration
Δ9-Tetrahydrocannabivarin Beneficial in Type 2 Diabetes
THCV significantly decreases fasting plasma glucose, improves pancreatic β-cell function
TBC1D4 Mutation Common in North American Inuit
TBC1D4 carriers with prediabetes, type 2 diabetes have increased risk of remaining undiagnosed
